Literature DB >> 22046063

Multiple myeloma presenting as acute renal failure.

Vincent C Kuo1, Andrew Z Fenves, Ankit N Mehta.   

Abstract

Entities:  

Year:  2011        PMID： 22046063      PMCID： PMC3205153          DOI： 10.1080/08998280.2011.11928744

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN： 0899-8280


× No keyword cloud information.
  25 in total

1.  Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridization.

Authors:  N Zojer; R Königsberg; J Ackermann; E Fritz; S Dallinger; E Krömer; H Kaufmann; L Riedl; H Gisslinger; S Schreiber; R Heinz; H Ludwig; H Huber; J Drach
Journal:  Blood       Date:  2000-03-15       Impact factor: 22.113

2.  Efficient removal of immunoglobulin free light chains by hemodialysis for multiple myeloma: in vitro and in vivo studies.

Authors:  Colin A Hutchison; Paul Cockwell; Steven Reid; Katie Chandler; Graham P Mead; John Harrison; John Hattersley; Neil D Evans; Mike J Chappell; Mark Cook; Hermann Goehl; Markus Storr; Arthur R Bradwell
Journal:  J Am Soc Nephrol       Date:  2007-01-17       Impact factor: 10.121

3.  International staging system for multiple myeloma.

Authors:  Philip R Greipp; Jesus San Miguel; Brian G M Durie; John J Crowley; Bart Barlogie; Joan Bladé; Mario Boccadoro; J Anthony Child; Herve Avet-Loiseau; Jean-Luc Harousseau; Robert A Kyle; Juan J Lahuerta; Heinz Ludwig; Gareth Morgan; Raymond Powles; Kazuyuki Shimizu; Chaim Shustik; Pieter Sonneveld; Patrizia Tosi; Ingemar Turesson; Jan Westin
Journal:  J Clin Oncol       Date:  2005-04-04       Impact factor: 44.544

4.  Beta-2-microglobulin is an independent predictor of progression in asymptomatic multiple myeloma.

Authors:  Davide Rossi; Marco Fangazio; Lorenzo De Paoli; Alessia Puma; Paola Riccomagno; Valeria Pinto; Paola Zigrossi; Antonio Ramponi; Guido Monga; Gianluca Gaidano
Journal:  Cancer       Date:  2010-05-01       Impact factor: 6.860

5.  Racial disparities in incidence and outcome in multiple myeloma: a population-based study.

Authors:  Adam J Waxman; Pamela J Mink; Susan S Devesa; William F Anderson; Brendan M Weiss; Sigurdur Y Kristinsson; Katherine A McGlynn; Ola Landgren
Journal:  Blood       Date:  2010-09-07       Impact factor: 22.113

6.  A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapy.

Authors:  A K Stewart; P L Bergsagel; P R Greipp; A Dispenzieri; M A Gertz; S R Hayman; S Kumar; M Q Lacy; J A Lust; S J Russell; T E Witzig; S R Zeldenrust; D Dingli; C B Reeder; V Roy; R A Kyle; S V Rajkumar; R Fonseca
Journal:  Leukemia       Date:  2007-01-18       Impact factor: 11.528

7.  BiRD (Biaxin [clarithromycin]/Revlimid [lenalidomide]/dexamethasone) combination therapy results in high complete- and overall-response rates in treatment-naive symptomatic multiple myeloma.

Authors:  Ruben Niesvizky; David S Jayabalan; Paul J Christos; Jessica R Furst; Tara Naib; Scott Ely; Jessica Jalbrzikowski; Roger N Pearse; Faiza Zafar; Karen Pekle; April Larow; Richard Lent; Tomer Mark; Hearn J Cho; Tsiporah Shore; Jeffrey Tepler; John Harpel; Michael W Schuster; Susan Mathew; John P Leonard; Madhu Mazumdar; Selina Chen-Kiang; Morton Coleman
Journal:  Blood       Date:  2007-11-07       Impact factor: 22.113

8.  Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group.

Authors: 
Journal:  Br J Haematol       Date:  2003-06       Impact factor: 6.998

9.  Prognostic value of the serum free light chain ratio in newly diagnosed myeloma: proposed incorporation into the international staging system.

Authors:  C L H Snozek; J A Katzmann; R A Kyle; A Dispenzieri; D R Larson; T M Therneau; L J Melton; S Kumar; P R Greipp; R J Clark; S V Rajkumar
Journal:  Leukemia       Date:  2008-07-03       Impact factor: 11.528

10.  Cancer statistics, 2009.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2009-05-27       Impact factor: 508.702
View more
  1 in total

1.  Multiple Myeloma Mimicking a Small Vessel Vasculitis Presentation.

Authors:  Mateo Mejía-Zuluaga; Jorge Andrés Lacouture; Maria Clara Gaviria; Maria Adelaida Garcés; Ana María Mejía; Sebastián Herrera
Journal:  Case Rep Rheumatol       Date:  2020-02-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.